New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy
- PMID: 9756823
- PMCID: PMC1113992
New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy
Comment on
-
New drug treatment for Alzheimer's disease: lessons for healthcare policy.BMJ. 1998 Mar 7;316(7133):762-4. doi: 10.1136/bmj.316.7133.762. BMJ. 1998. PMID: 9529416 Free PMC article. Review. No abstract available.
References
-
- Eagger SA, Levy R, Sahakian BJ. Tacrine in Alzheimer’s disease. Lancet. 1991;337:989–992. - PubMed
-
- Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J. A controlled trial of tacrine in Alzheimer’s disease. JAMA. 1992;268:2523–2529. - PubMed
-
- Siegfried K. Neurotransmitter-based treatment of Alzheimer’s disease: the example of velnacrine. In: Levy R, Howard R, editors. Developments in dementia and functional disorders in the elderly. Petersfield: Wrightson Biomedical; 1995. pp. 77–83.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical